jama ophthalmology semaglutide use linked with increased risk for NAION in patients with diabetes Ischemic optic neuropathy with semaglutide:

Benefits BPC-157 offers a wide range of benefits that make it valuable for patients dealing with injuries, chronic conditions, or gastrointestinal concerns

doi: 10.3390/foods14132397 15 JensterleMDeVriesJHBattelinoTBattelinoSYildizBJanezA

As Wegovy, it received FDA approval specifically for the treatment of obesity in 2021

Semaglutide should not be given to patients who have a history of pancreatitis , thyroid tumors , thyroid cancer , or a family history of thyroid malignancies or tumors

Thymosin Beta 4 has not been evaluated for tendon or muscle regeneration, but the peptide may accelerate musculoskeletal healing following injury and exercise